235 related articles for article (PubMed ID: 29873340)
21. [Role of semen-derived amyloid fibrils as facilitators of HIV infection].
Roan NR; Cavrois M; Greene WC
Med Sci (Paris); 2012 Apr; 28(4):358-60. PubMed ID: 22549858
[No Abstract] [Full Text] [Related]
22. Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.
French KC; Roan NR; Makhatadze GI
Biochemistry; 2014 May; 53(20):3267-77. PubMed ID: 24811874
[TBL] [Abstract][Full Text] [Related]
23. Functional amyloids of eukaryotes: criteria, classification, and biological significance.
Sergeeva AV; Galkin AP
Curr Genet; 2020 Oct; 66(5):849-866. PubMed ID: 32356034
[TBL] [Abstract][Full Text] [Related]
24. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.
Taylor S; Sadiq ST; Weller I; Kaye S; Workman J; Cane PA; Bennett J; Copas AJ; Drake SM; Pillay D
Antivir Ther; 2003 Oct; 8(5):479-83. PubMed ID: 14640396
[TBL] [Abstract][Full Text] [Related]
25. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission.
Krieger JN; Coombs RW; Collier AC; Ho DD; Ross SO; Zeh JE; Corey L
J Urol; 1995 Sep; 154(3):1035-40. PubMed ID: 7637049
[TBL] [Abstract][Full Text] [Related]
26. Amyloid formation: functional friend or fearful foe?
Bergman P; Roan NR; Römling U; Bevins CL; Münch J
J Intern Med; 2016 Aug; 280(2):139-52. PubMed ID: 27151743
[TBL] [Abstract][Full Text] [Related]
27. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.
Gottlieb GS; Hawes SE; Agne HD; Stern JE; Critchlow CW; Kiviat NB; Sow PS
AIDS; 2006 Apr; 20(6):895-900. PubMed ID: 16549974
[TBL] [Abstract][Full Text] [Related]
28. A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection.
Chen J; Ren R; Yu F; Wang C; Zhang X; Li W; Tan S; Jiang S; Liu S; Li L
Biophys J; 2017 Oct; 113(7):1425-1439. PubMed ID: 28978437
[TBL] [Abstract][Full Text] [Related]
29. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
[TBL] [Abstract][Full Text] [Related]
30. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
Marcelin AG; Tubiana R; Lambert-Niclot S; Lefebvre G; Dominguez S; Bonmarchand M; Vauthier-Brouzes D; Marguet F; Mousset-Simeon N; Peytavin G; Poirot C
AIDS; 2008 Aug; 22(13):1677-9. PubMed ID: 18670231
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the effect of macromolecular crowding on aggregation behaviour of a model amyloidogenic Peptide.
Gaharwar B; Gour S; Kaushik V; Gupta N; Kumar V; Hause G; Yadav JK
Protein Pept Lett; 2015; 22(1):87-93. PubMed ID: 25267253
[TBL] [Abstract][Full Text] [Related]
32. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
[TBL] [Abstract][Full Text] [Related]
33. Proteomics of boar seminal plasma - current studies and possibility of their application in biotechnology of animal reproduction.
Strzeżek J; Wysocki P; Kordan W; Kuklińska M; Mogielnicka M; Soliwoda D; Fraser L
Reprod Biol; 2005 Nov; 5(3):279-90. PubMed ID: 16372045
[TBL] [Abstract][Full Text] [Related]
34. Critical Review: Immunomodulation by Seminal Factors and Implications for Male-to-Female HIV-1 Transmission.
Keogan S; Siegert K; Wigdahl B; Krebs FC
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):131-7. PubMed ID: 25642971
[TBL] [Abstract][Full Text] [Related]
35. Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE network.
Pasquier C; Andreutti C; Bertrand E; Bostan A; Bourlet T; Molina I; Grossman Z; Halfon P; Leruez-Ville M; Lüneborg-Nielsen M; Mar C; Marcelin AG; Roussel-Ronserail C; Schmitt MP; Tabrizi S; Vourliotis M; Bujan L
J Med Virol; 2012 Feb; 84(2):183-7. PubMed ID: 22170535
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates.
Kalichman SC; Cage M; Barnett T; Tharnish P; Rompa D; Austin J; Luke W; O'Mowrey J; Schinazi RF
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1695-703. PubMed ID: 11788021
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of Ebola virus infection by seminal amyloid fibrils.
Bart SM; Cohen C; Dye JM; Shorter J; Bates P
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7410-7415. PubMed ID: 29941593
[TBL] [Abstract][Full Text] [Related]
38. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.
Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S
J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963
[TBL] [Abstract][Full Text] [Related]
39. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
Pereira AS; Kashuba AD; Fiscus SA; Hall JE; Tidwell RR; Troiani L; Dunn JA; Eron JJ; Cohen MS
J Infect Dis; 1999 Dec; 180(6):2039-43. PubMed ID: 10558966
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M;
Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
